Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinoma. Iida Y, Churchman M, Hollis RL, Taylor S, et al. Gynecol Oncol 2025;198:66-74.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Iida Y, Churchman M, Hollis RL, Taylor S, et al. Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinoma. Gynecol Oncol 2025;198:66-74.
PMID: 40435541